Literature DB >> 39160

Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.

R M Ferris, F L Tang.   

Abstract

The ATP-Mg++-dependent uptake of [3H]dopamine and l-[3H]norepinephrine into purified synaptic vesicles of whole rat brain, rat striatum and rat hypothalamus was inhibited 10-fold more effectively by S-(+)-amphetamine as compared to its corresponding (R-(-)-enantiomer. In contrast, S-(+)-deoxypipradrol and its R-(-)-enantiomer were approximately equipotent inhibitors of 3H-amine uptake into these synaptic vesicular preparations. The 1R:2R-methylphenidate was twice as potent as its 1R:2S-enantiomer as an inhibitor of 3H-catecholamine uptake. These data suggest that the receptor sites on the amine pumps present in the membranes of all three vesicular preparations are similar in so far as they are all sensitive to the stereochemical configuration around the alpha-carbon of amphetamine but are not sensitive to the stereochemical configuration around the analogous carbon of deoxypipradrol and methylphenidate. These observations are the reverse of those previously observed for the phenethylamine pumps present in peripheral and central neuronal membranes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39160

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.

Authors:  E J Marijke Achterberg; Linda W M van Kerkhof; Ruth Damsteegt; Viviana Trezza; Louk J M J Vanderschuren
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

2.  Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.

Authors:  Amanda R Moraska; Amit Sood; Shaker R Dakhil; Jeff A Sloan; Debra Barton; Pamela J Atherton; Jason J Suh; Patricia C Griffin; David B Johnson; Aneela Ali; Peter T Silberstein; Steven F Duane; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

Review 3.  Pharmacokinetics and clinical effectiveness of methylphenidate.

Authors:  H C Kimko; J T Cross; D R Abernethy
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 4.  New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.

Authors:  Daniel F Connor; Ronald J Steingard
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior.

Authors:  Kimberly A Young; Kyle L Gobrogge; Zuoxin Wang
Journal:  Neurosci Biobehav Rev       Date:  2010-06-23       Impact factor: 8.989

6.  PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Authors:  Tyler Stevens; Katrin Sangkuhl; Jacob T Brown; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-08       Impact factor: 2.089

7.  Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.

Authors:  Moon-Soo Lee; Jae-Won Yang; Young-Hoon Ko; Changsu Han; Seung-Hyun Kim; Min-Soo Lee; Sook-Haeng Joe; In-Kwa Jung
Journal:  Child Psychiatry Hum Dev       Date:  2007-08-31

8.  Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate.

Authors:  Soyon Ahn; Anthony G Phillips
Journal:  ACS Chem Neurosci       Date:  2013-05-03       Impact factor: 4.418

9.  Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans.

Authors:  N R Srinivas; J W Hubbard; E D Korchinski; K K Midha
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

10.  Methylphenidate disrupts social play behavior in adolescent rats.

Authors:  Louk J M J Vanderschuren; Viviana Trezza; Sanne Griffioen-Roose; Olga J G Schiepers; Natascha Van Leeuwen; Taco J De Vries; Anton N M Schoffelmeer
Journal:  Neuropsychopharmacology       Date:  2008-02-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.